204 related articles for article (PubMed ID: 15879345)
1. Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.
Wright CB; Paik MC; Brown TR; Stabler SP; Allen RH; Sacco RL; DeCarli C
Stroke; 2005 Jun; 36(6):1207-11. PubMed ID: 15879345
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study.
Seshadri S; Wolf PA; Beiser AS; Selhub J; Au R; Jacques PF; Yoshita M; Rosenberg IH; D'Agostino RB; DeCarli C
Arch Neurol; 2008 May; 65(5):642-9. PubMed ID: 18474741
[TBL] [Abstract][Full Text] [Related]
3. Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.
Miwa K; Tanaka M; Okazaki S; Yagita Y; Sakaguchi M; Mochizuki H; Kitagawa K
J Alzheimers Dis; 2016; 49(2):503-13. PubMed ID: 26484913
[TBL] [Abstract][Full Text] [Related]
4. Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study.
Wright CB; Lee HS; Paik MC; Stabler SP; Allen RH; Sacco RL
Neurology; 2004 Jul; 63(2):254-60. PubMed ID: 15277617
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine as a risk factor for cognitive impairment in stroke patients.
Sachdev PS; Valenzuela MJ; Brodaty H; Wang XL; Looi J; Lorentz L; Howard L; Jones M; Zagami AS; Gillies D; Wilcken DE
Dement Geriatr Cogn Disord; 2003; 15(3):155-62. PubMed ID: 12584431
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine, white matter hyperintensities, and cognition in healthy elderly people.
Dufouil C; Alpérovitch A; Ducros V; Tzourio C
Ann Neurol; 2003 Feb; 53(2):214-21. PubMed ID: 12557288
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease is associated with white matter hyperintensity volume: the Northern Manhattan Study (NOMAS).
Khatri M; Wright CB; Nickolas TL; Yoshita M; Paik MC; Kranwinkel G; Sacco RL; DeCarli C
Stroke; 2007 Dec; 38(12):3121-6. PubMed ID: 17962588
[TBL] [Abstract][Full Text] [Related]
8. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
[TBL] [Abstract][Full Text] [Related]
9. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients.
Tseng YL; Chang YY; Liu JS; Su CS; Lai SL; Lan MY
J Neurol Sci; 2009 Sep; 284(1-2):36-9. PubMed ID: 19398115
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia.
Flicker L; Vasikaran SD; Thomas J; Acres JM; Norman P; Jamrozik K; Hankey GJ; Almeida OP
Stroke; 2006 Feb; 37(2):547-9. PubMed ID: 16373648
[TBL] [Abstract][Full Text] [Related]
11. B-vitamins and homocysteine in Spanish institutionalized elderly.
Gonzalez-Gross M; Sola R; Albers U; Barrios L; Alder M; Castillo MJ; Pietrzik K
Int J Vitam Nutr Res; 2007 Jan; 77(1):22-33. PubMed ID: 17685092
[TBL] [Abstract][Full Text] [Related]
12. Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study.
Dong C; Nabizadeh N; Caunca M; Cheung YK; Rundek T; Elkind MS; DeCarli C; Sacco RL; Stern Y; Wright CB
Neurology; 2015 Aug; 85(5):441-9. PubMed ID: 26156514
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; van der Graaf Y; Geerlings MI
Atherosclerosis; 2011 Jun; 216(2):461-6. PubMed ID: 21411090
[TBL] [Abstract][Full Text] [Related]
14. Brain MRI, apoliprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls.
Weiner MF; de la Plata CM; Fields BA; Womack KB; Rosenberg RN; Gong YH; Qu BX; Diaz-Arrastia R; Hynan LS
Curr Alzheimer Res; 2009 Feb; 6(1):52-8. PubMed ID: 19199875
[TBL] [Abstract][Full Text] [Related]
15. Sleep duration is associated with white matter hyperintensity volume in older adults: the Northern Manhattan Study.
Ramos AR; Dong C; Rundek T; Elkind MS; Boden-Albala B; Sacco RL; Wright CB
J Sleep Res; 2014 Oct; 23(5):524-30. PubMed ID: 25040435
[TBL] [Abstract][Full Text] [Related]
16. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease.
Pavlovic AM; Pekmezovic T; Obrenovic R; Novakovic I; Tomic G; Mijajlovic M; Sternic N
Clin Neurol Neurosurg; 2011 Nov; 113(9):711-5. PubMed ID: 21802199
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.
Towfighi A; Arshi B; Markovic D; Ovbiagele B
Cerebrovasc Dis; 2014; 37(4):263-7. PubMed ID: 24751920
[TBL] [Abstract][Full Text] [Related]
18. Total plasma homocysteine, folate, and vitamin B12 status in healthy Iranian adults: the Tehran homocysteine survey (2003-2004)/a cross-sectional population based study.
Fakhrzadeh H; Ghotbi S; Pourebrahim R; Nouri M; Heshmat R; Bandarian F; Shafaee A; Larijani B
BMC Public Health; 2006 Feb; 6():29. PubMed ID: 16472406
[TBL] [Abstract][Full Text] [Related]
19. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study.
Alsulaimani S; Gardener H; Elkind MS; Cheung K; Sacco RL; Rundek T
Stroke; 2013 Feb; 44(2):457-61. PubMed ID: 23287787
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.
Sacco RL; Anand K; Lee HS; Boden-Albala B; Stabler S; Allen R; Paik MC
Stroke; 2004 Oct; 35(10):2263-9. PubMed ID: 15345803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]